• to decrease the risk of severe cardiovascular (coronary heart and blood vessel) difficulties in Older people with kind 2 diabetes and heart problemsIn October 2024, Novo Nordisk released a analyze on scientific journal Character a couple of novel glucose-delicate insulin NNC2215 that may lessen the potential risk of hypoglycemia in animal versi